D16 - A Dialogue With ORI

Thursday, November 18, 2021

1:30 PM – 2:30 PM ET

Location: On-Demand

Sponsored By

Join representatives from ORI for a session that will provide insight into an institutional response to allegations of clinical research misconduct and protocol violations, ORI’s oversight review of the institutional process, and identification of research misconduct in translational and clinical research, as part of the research continuum. This session will include case examples and the implementation of the federal regulations at 42 C.F.R. Part 93, to address
allegations of research misconduct.

Learning Objectives:

Discuss ORI’s mission and jurisdiction
Consider each ORI’s, DEI’s, and DIO’s responses to research misconduct
Explore the distinction between clinical research misconduct and a protocol violation
Discuss NIH’s working definition of translational research
Use case studies to show how to address allegations of research misconduct in translational research, as well as institutions’ versus ORI’s response to clinical research misconduct allegations

Presenter(s)

Yvette M. Carter, MD

Office of Research Integrity, Department of Health and Human Services
Rockville, MD
ND

Ning Du, MD, PhD

Department of Health and Human Services